Literature DB >> 6764226

Clinical study on the psychotropic effects of caerulein--an open clinical trial in chronic schizophrenic patients.

H Itoh, S Tanoue, G Yagi, M Tateyama, M Kamisada, Y Fujii, M Takamiya, S Nakajima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6764226     DOI： 10.2302/kjm.31.71

Source DB:  PubMed          Journal:  Keio J Med        ISSN： 0022-9717


× No keyword cloud information.
  2 in total

1.  Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.

Authors:  E Peselow; B Angrist; A Sudilovsky; J Corwin; J Siekierski; F Trent; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Neuropeptides: animal behaviour and human psychopathology.

Authors:  D de Wied; J M van Ree
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.